- Why Invest
- Business Operations
- Key Industries
- How We Help
- Success Stories
- Contact Us
“Molecular imaging is continuously expanding: it is increasingly being combined with advanced technologies such as artificial intelligence and has become a principal component of medical imaging. In the therapy field, targeted radiopharmaceuticals have been demonstrated to be effective and are increasingly used in a variety of clinical settings, often integrated with other therapeutic options. The ultimate goal is to design personalised, super-selective therapies and to identify more precise means of monitoring response to treatment in routine clinical practice.” Francesco Giammarile, EANM Congress Chair 2017–2019.
With more than 150 sessions, the European Association of Nuclear Medicine (EANM) Annual Congress is the most valuable Nuclear Medicine Meeting worldwide. Each year, more than 6,200 participants have the possibility to network, socialize and discuss the newest trends and findings in the field of Nuclear Medicine. The EANM is proud of receiving approximately 2,200 abstracts annually from all over Europe and overseas. 160 exhibiting companies, covering an area of 3,500 sqm present their newest technologies.
The Invest in Holland Life Sciences & Health team will be present on this event. Let’s connect!